)
Pro Medicus (PME) investor relations material
Pro Medicus H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue increased 28.4% year-over-year to $124.8m, with underlying EBIT up 29.7% and improved EBIT margins; after-tax profit surged 230.9% to $171.2m, driven by a $149.1m unrealised gain on a 4D Medical investment and strong operational growth.
Achieved record half with seven new contracts totaling over AUD 280 million, including a $170m/10-year deal with University of Colorado Health and a major contract with University of Heidelberg.
Completed six cloud-based implementations and reported the busiest RSNA conference to date, generating significant new leads.
Maintains a strong balance sheet with $221.8m in cash and investments, up 5.3%, and remains debt free despite higher dividends, share buybacks, and investments.
Significant progress in expanding product suite to cardiology and pathology, with first major cardiology sale and imminent pathology launch.
Financial highlights
Underlying EBIT reached $90.7m, up 29.7% year-over-year, with EBIT margins at 72.6%.
Interim dividend increased 28% to AUD 0.32 per share, fully franked, with $33.4m declared for the interim period.
Realized an unrealized gain of approximately $149.1m from a hybrid debt/equity investment in 4D Medical.
Cash and investments at $221.8m, up 5.3% year-over-year.
Gross profit reached $128.8m, with a gross margin of nearly 100%.
Outlook and guidance
Expect revenue acceleration in the second half as large contracts ramp up, with five Trinity cohorts to be completed by July, representing about 80-85% of the contract.
Pipeline remains robust across all market segments and sizes, with strong network effects from flagship implementations.
Forward contracted revenue for five years surpassed AUD 1 billion, providing strong revenue visibility.
Sufficient cash reserves are available to fund anticipated growth internally.
Interim dividend of 32.0c per share declared, payable in March 2026.
Next Pro Medicus earnings date
Next Pro Medicus earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)